StockVS

M Evo Global Acquisition Corp II (MEVOU) Aandelenanalyse

Financiële Diensten

M Evo Global Acquisition Corp II

$10.10

+$0.04 (+0.40%)

Laatst bijgewerkt: 26 mei 2026

Koersverloop

Analyse

Bedrijfsoverzicht

M Evo Global Acquisition Corp II is a special purpose acquisition company that focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, operating within the Financial Services sector as a shell company. The entity was incorporated in 2025 and maintains its headquarters in Farmers Branch, Texas, positioning itself as a vehicle designed to identify and complete business combinations with private or public operating companies. In terms of scale, the company's market cap is listed as N/A, and its annual revenue is currently N/A, while the specific employee count is not disclosed in available data. These valuation metrics indicate that the company exists primarily as a financial vehicle awaiting a target transaction rather than an established operating enterprise with significant revenue generation or a large workforce typical of mature financial services firms. The absence of traditional scale indicators such as market capitalization and revenue suggests that the primary asset value lies in the potential of the pending business combination rather than current operational performance, which is characteristic of SPAC structures in the early stages of their lifecycle.

Financiële gezondheid

The financial statements for M Evo Global Acquisition Corp II show a Net Income (TTM) of $-119,861, while Revenue (TTM) and EBITDA are both listed as N/A, revealing a cost structure where expenses significantly outweigh the currently unquantified revenue streams typical of a shell company structure. Free Cash Flow is not available for reporting, which implies that the company does not yet generate positive cash flow from operations to fund activities independently, relying instead on its trust account or capital markets for liquidity. All three margin metrics—Gross Margin, Operating Margin, and Profit Margin—are recorded at 0.0%, indicating that the company has not yet generated positive gross profit or operating income relative to its revenue base, a standard characteristic for SPACs prior to completing a business combination. When comparing total cash and total debt, the company holds N/A in cash against a debt load of $10, resulting in a Debt to Equity ratio of 0.06 which suggests a balance sheet with minimal leverage relative to equity, though the low cash position limits immediate financial flexibility. The Current Ratio stands at 0.11, indicating that the company's current assets are significantly lower than its current liabilities, which points to potential short-term liquidity constraints that are common for shell companies awaiting a merger to unlock capital. Return on Equity and Return on Assets are both listed as N/A, meaning these return metrics cannot yet be calculated to evaluate management effectiveness, as the traditional denominators of equity and assets are not yet yielding returns in the conventional sense.

Waarderingsbeoordeling

The trailing P/E ratio and forward P/E are both listed as N/A, meaning no meaningful difference between them can be calculated to imply an expected earnings trajectory at this stage since the company is not yet profitable. The Price to Book ratio is listed at -3336.67, a figure that indicates a significant market premium or discount relative to book value that is mathematically anomalous for a standard operating company and likely reflects the specific accounting treatment of the shell structure or trust account valuation rather than traditional equity value. The Price to Sales ratio and EV/EBITDA are both unavailable, suggesting that these alternative valuation metrics cannot be utilized to assess the company's value proposition without completed transaction data. Regarding price metrics, the 52-Week High is $10.50 and the 52-Week Low is $10.01; without a specific current share price provided in the facts, the exact percentage deviation from this range cannot be calculated, but the narrow trading band indicates low volatility typical for unlisted or recently formed SPACs. The Beta value is listed as N/A, which implies that the company's price volatility relative to the broader market cannot be statistically determined due to limited trading history or lack of market data integration for this specific ticker. These valuation limitations underscore that traditional metrics used to assess mature financial institutions are not applicable to an entity in the pre-merger phase where value is contingent on future business combination terms.

Growth & Income

The Revenue Growth (YoY) and Earnings Growth (YoY) rates are both listed as N/A, indicating that earnings are neither growing faster nor slower than revenue because both figures are currently undefined for the period. As the company is not a dividend payer, there is no Dividend Yield or Payout Ratio to report, which means the company reinvests its available resources into the search for a business combination target rather than distributing income to shareholders. The overall growth and income profile is characterized by a lack of historical growth data and a complete absence of dividend income, reflecting the strategic nature of the business model focused on capital preservation and eventual merger execution rather than current income generation or organic growth. This profile necessitates that investors evaluate the potential for future value creation solely based on the success of the pending merger rather than current financial performance or dividend history.

Vergelijking met sectorgenoten

M Evo Global Acquisition Corp II (MEVOU) is actief in de Lege Vennootschappen-sector. Zo verhoudt het zich tot de naaste sectorgenoten op basis van marktkapitalisatie:

Bedrijf Ticker Marktkapitalisatie K/W-verhouding
M Evo Global Acquisition Corp II MEVOU N/A N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

De gemiddelde K/W-verhouding in de Lege Vennootschappen-sector is 82.8x. M Evo Global Acquisition Corp II wordt verhandeld tegen een K/W van N/A.

Deze analyse is gegenereerd door AI en dient alleen ter informatie. Het vormt geen financieel advies. Gegevens kunnen vertraagd of onnauwkeurig zijn. Doe altijd je eigen onderzoek en raadpleeg een gekwalificeerde financieel adviseur voordat je beleggingsbeslissingen neemt.

Over M Evo Global Acquisition Corp II

M Evo Global Acquisition Corp II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2025 and is headquartered in Farmers Branch, Texas.

Bedrijfsbeschrijving wordt in het Engels weergegeven.

Belangrijke Cijfers

Marktkapitalisatie
N/A
K/W-verhouding
N/A
52-weken hoog
$10.50
52-weken laag
$10.01
Gem. Volume
8.97K

Gegevens verstrekt door Yahoo Finance via yfinance. Dagelijks bijgewerkt.

Bedrijfsinfo

Beurs
NASDAQ
Land
United States